A Swiss CBD company has questioned the approach of European authorities in demanding further data in order to advance novel food applications, describing it as an issue that might signal the end of hemp-extracted cannabinoids as a viable sector in the EU.

Linnea, a Swiss provider of ingredients for the pharmaceutical, cosmetics, and dietary supplement industries, has two applications now on hold with the European Food Safety Authority (EFSA).

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Swiss CBD company takes issue with EFSA’s delay of novel food applications ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Swiss CBD company takes issue with EFSA’s delay of novel food applications ”






      A Swiss CBD company has questioned the approach of European authorities in demanding further data in order to advance novel food applications, describing it as an issue that might signal the end of hemp-extracted cannabinoids as a viable sector in the EU.

      Linnea, a Swiss provider of ingredients for the pharmaceutical, cosmetics, and dietary supplement industries, has two applications now on hold with the European Food Safety Authority (EFSA).

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik